Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


18.06.2018

9 Am Heart J
3 Ann Thorac Surg
2 Chest
4 Circ Cardiovasc Interv
2 Circ Cardiovasc Qual Outcomes
2 Circ Genom Precis Med
2 Circ Heart Fail
1 Circ J
2 Circ Res
9 Circulation
2 Clin Cardiol
1 Dtsch Med Wochenschr
1 Heart
11 Int J Cardiol
5 J Am Coll Cardiol
4 JAMA
2 N Engl J Med
2 Thromb Haemost


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. LATTUCA B, Barber-Chamoux N, Alos B, Sfaxi A, et al
    Impact of video on the understanding and satisfaction of patients receiving informed consent before elective inpatient coronary angiography: A randomized trial.
    Am Heart J. 2018;200:67-74.
    PubMed     Text format     Abstract available

  2. LOPES RD, Vora AN, Liaw D, Granger CB, et al
    An open-Label, 2 x 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention:
    Am Heart J. 2018;200:17-23.
    PubMed     Text format     Abstract available

  3. PASTORI D, Pignatelli P, Cribari F, Carnevale R, et al
    Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation.
    Am Heart J. 2018;200:32-36.
    PubMed     Text format     Abstract available

  4. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
    The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial.
    Am Heart J. 2018;200:83-89.
    PubMed     Text format     Abstract available

  5. ELFWEN L, Lagedal R, James S, Jonsson M, et al
    Coronary angiography in out-of-hospital cardiac arrest without ST elevation on ECG-Short- and long-term survival.
    Am Heart J. 2018;200:90-95.
    PubMed     Text format     Abstract available

  6. CARSON JL, Stanworth SJ, Alexander JH, Roubinian N, et al
    Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease.
    Am Heart J. 2018;200:96-101.
    PubMed     Text format     Abstract available

  7. CAPLICE NM, DeVoe MC, Choi J, Dahly D, et al
    Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
    Am Heart J. 2018;200:110-117.
    PubMed     Text format     Abstract available

  8. ISRAR MZ, Heaney LM, Ng LL, Suzuki T, et al
    B-type natriuretic peptide molecular forms for risk stratification and prediction of outcome after acute myocardial infarction.
    Am Heart J. 2018;200:37-43.
    PubMed     Text format     Abstract available

  9. HJORT M, Lindahl B, Baron T, Jernberg T, et al
    Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries.
    Am Heart J. 2018;200:60-66.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  10. ASADA S, Yamagishi M, Nishida K, Okazaki S, et al
    Anomalous Origin of Left Coronary Artery from Aortic Arch Associated with HLHS.
    Ann Thorac Surg. 2018 Jun 8. pii: S0003-4975(18)30824.
    PubMed     Text format     Abstract available

  11. WEBER DJ, Sheikh AY, Cain BS, LaBourene JI, et al
    Repair of Enlarging Left Ventricular Pseudoaneurysm Two Months After Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2018 Jun 8. pii: S0003-4975(18)30826.
    PubMed     Text format     Abstract available

  12. KITAMURA S
    Pediatric Coronary Artery Bypass Surgery for Congenital Heart Disease.
    Ann Thorac Surg. 2018 Jun 5. pii: S0003-4975(18)30752.
    PubMed     Text format     Abstract available


    Chest

  13. CAZZOLA M, Matera MG
    Combining Dual Bronchodilation and beta-Blockade in Patients With an Overlap Between COPD and Cardiovascular Diseases.
    Chest. 2018;153:1289-1291.
    PubMed     Text format    

  14. BHATT SP, Kazerooni EA, Newell JD Jr, Hokanson JE, et al
    Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD.
    Chest. 2018 Jun 8. pii: S0012-3692(18)30888-2. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  15. DILLINGER JG, Ducrocq G, Elbez Y, Cohen M, et al
    Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From th
    Circ Cardiovasc Interv. 2018;11:e006084.
    PubMed     Text format     Abstract available

  16. SONG C, Sukul D, Seth M, Wohns D, et al
    Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Circ Cardiovasc Interv. 2018;11:e006400.
    PubMed     Text format     Abstract available

  17. KOCHAR A, Li Z, Harrison JK, Hughes GC, et al
    Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement.
    Circ Cardiovasc Interv. 2018;11:e006322.
    PubMed     Text format     Abstract available

  18. FAXON DP, Leopold JA, Abbott JD, McElhinney DB, et al
    Circulation: Cardiovascular Interventions: The First 10 Years.
    Circ Cardiovasc Interv. 2018;11:e006901.
    PubMed     Text format    


    Circ Cardiovasc Qual Outcomes

  19. DREYER RP, Dickson VV
    Return to Work After Acute Myocardial Infarction: The Importance of Patients' Preferences.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004806.
    PubMed     Text format    

  20. WARRAICH HJ, Kaltenbach LA, Fonarow GC, Peterson ED, et al
    Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004528.
    PubMed     Text format     Abstract available


    Circ Genom Precis Med

  21. GUTIERREZ OM, Irvin MR, Chaudhary NS, Cushman M, et al
    APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults.
    Circ Genom Precis Med. 2018;11:e002098.
    PubMed     Text format     Abstract available

  22. WAITZMAN JS, Wilkins JT, Lin J
    APOL1 Sends Its REGARDS to Cardiovascular Disease.
    Circ Genom Precis Med. 2018;11:e002212.
    PubMed     Text format    


    Circ Heart Fail

  23. KONERMAN MC, Lazarus JJ, Weinberg RL, Shah RV, et al
    Reduced Myocardial Flow Reserve by Positron Emission Tomography Predicts Cardiovascular Events After Cardiac Transplantation.
    Circ Heart Fail. 2018;11:e004473.
    PubMed     Text format     Abstract available

  24. TURKIEH A, Fertin M, Bouvet M, Mulder P, et al
    Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction.
    Circ Heart Fail. 2018;11:e004838.
    PubMed     Text format     Abstract available


    Circ J

  25. FU R, Song C, Yang J, Wang Y, et al
    CAMI-NSTEMI Score- China Acute Myocardial Infarction Registry-Derived Novel Tool to Predict In-Hospital Death in Non-ST Segment Elevation Myocardial Infarction Patients.
    Circ J. 2018 Jun 8. doi: 10.1253/circj.CJ-17-1078.
    PubMed     Text format     Abstract available


    Circ Res

  26. FLORAS JS
    Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor.
    Circ Res. 2018;122:1741-1764.
    PubMed     Text format     Abstract available

  27. POPE CA 3RD, Cohen AJ, Burnett RT
    Cardiovascular Disease and Fine Particulate Matter: Lessons and Limitations of an Integrated Exposure-Response Approach.
    Circ Res. 2018;122:1645-1647.
    PubMed     Text format    


    Circulation

  28. UDDIN SMI, Mirbolouk M, Dardari Z, Feldman DI, et al
    Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2018 Jun 11. pii: CIRCULATIONAHA.118.033990.
    PubMed     Text format     Abstract available

  29. ROBERTS R
    Genetic Risk Stratification: Tipping Point for Global Primary Prevention of Coronary Artery Disease.
    Circulation. 2018;137:2554-2556.
    PubMed     Text format    

  30. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Circulation. 2018;137:2635-2650.
    PubMed     Text format     Abstract available

  31. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    PubMed     Text format    

  32. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    PubMed     Text format    

  33. ZHANG M, Solomon DH, Desai RJ, Kang EH, et al
    Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study.
    Circulation. 2018 Jun 13. pii: CIRCULATIONAHA.118.033992.
    PubMed     Text format     Abstract available

  34. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    PubMed     Text format    

  35. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    PubMed     Text format    

  36. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    PubMed     Text format    


    Clin Cardiol

  37. OSIBOGUN O, Ogunmoroti O, Spatz ES, Burke GL, et al
    Is self-rated health associated with ideal cardiovascular health? The Multi-Ethnic Study of Atherosclerosis.
    Clin Cardiol. 2018 Jun 12. doi: 10.1002/clc.22995.
    PubMed     Text format     Abstract available

  38. HU WS, Lin CL
    Use of the adapted diabetes complications severity index to predict acute coronary syndrome, ischemic stroke and mortality in Asian patients with type 2 diabetes mellitus: a nationwide cohort investigation.
    Clin Cardiol. 2018 Jun 12. doi: 10.1002/clc.22991.
    PubMed     Text format     Abstract available


    Dtsch Med Wochenschr

  39. MICHELS G, Kuffer L, Adler C, Bokredenghel S, et al
    [60-Year Old Woman with Dyspnea in Cardiogenic Shock].
    Dtsch Med Wochenschr. 2018;143:191-192.
    PubMed     Text format    


    Heart

  40. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    PubMed     Text format    


    Int J Cardiol

  41. QIN F, Sun C, Ma Y, Liu C, et al
    Is low serum albumin concentration associated with the adverse cardiovascular events in stable coronary heart disease?
    Int J Cardiol. 2018;266:260.
    PubMed     Text format    

  42. ZHENG Y, Li T
    Letter to the Editor concerning the article "Machine learning for prediction of 30-day mortality after ST elevation myocardial infarction".
    Int J Cardiol. 2018;266:41.
    PubMed     Text format    

  43. WILDI K, Singeisen H, Twerenbold R, Badertscher P, et al
    Circadian rhythm of cardiac troponin I and its clinical impact on the diagnostic accuracy for acute myocardial infarction.
    Int J Cardiol. 2018 Jun 4. pii: S0167-5273(17)37970.
    PubMed     Text format     Abstract available

  44. ZHANG J, Yu L, Xu Y, Liu Y, et al
    Long noncoding RNA upregulated in hypothermia treated cardiomyocytes protects against myocardial infarction through improving mitochondrial function.
    Int J Cardiol. 2018;266:213-217.
    PubMed     Text format     Abstract available

  45. JONES DA, Rathod KS, Williamson A, Harrington D, et al
    The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction.
    Int J Cardiol. 2018;266:1-6.
    PubMed     Text format     Abstract available

  46. NUCIFORA G, Muser D, Tioni C, Shah R, et al
    Prognostic value of myocardial deformation imaging by cardiac magnetic resonance feature-tracking in patients with a first ST-segment elevation myocardial infarction.
    Int J Cardiol. 2018 May 26. pii: S0167-5273(18)31109.
    PubMed     Text format     Abstract available

  47. RIAHI SM, Moamer S, Namdari M, Mokhayeri Y, et al
    Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
    Int J Cardiol. 2018 May 24. pii: S0167-5273(17)37027.
    PubMed     Text format     Abstract available

  48. SAMANTA R, Pouliopoulos J, Kumar S, Narayan A, et al
    Influence of BMI on inducible ventricular tachycardia and mortality in patients with myocardial infarction and left ventricular dysfunction: The obesity paradox.
    Int J Cardiol. 2018;265:148-154.
    PubMed     Text format     Abstract available

  49. SIM DS, Kim W, Lee KH, Song HC, et al
    Cardioprotective effect of substance P in a porcine model of acute myocardial infarction.
    Int J Cardiol. 2018 May 31. pii: S0167-5273(18)32255.
    PubMed     Text format     Abstract available

  50. SAAD M, Stiermaier T, Fuernau G, Poss J, et al
    Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction.
    Int J Cardiol. 2018;265:251-255.
    PubMed     Text format     Abstract available

  51. JIANG X, Asmaro R, O'Sullivan DM, Modi J, et al
    Depression may be a risk factor for coronary heart disease in midlife women <65years: A 9-year prospective cohort study.
    Int J Cardiol. 2018 May 24. pii: S0167-5273(18)31359.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  52. KIM JM, Stewart R, Kim JW, Kang HJ, et al
    Serotonin Transporter Gene Association Between Anxiety and Long-Term Cardiac Outcomes in Acute Coronary Syndromes.
    J Am Coll Cardiol. 2018;71:2706-2707.
    PubMed     Text format    

  53. ODQVIST M, Andersson PO, Tygesen H, Eggers KM, et al
    High-Sensitivity Troponins and Outcomes After Myocardial Infarction.
    J Am Coll Cardiol. 2018;71:2616-2624.
    PubMed     Text format     Abstract available

  54. MOTOVSKA Z, Hlinomaz O, Kala P
    Reply: Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials.
    J Am Coll Cardiol. 2018;71:2711-2712.
    PubMed     Text format    

  55. HAN JJ, Brown CR
    The Heart Team: A Powerful Paradigm for the Future Training of Cardiovascular Surgeons.
    J Am Coll Cardiol. 2018;71:2702-2705.
    PubMed     Text format    

  56. LOZANO I, Lopez-Palop R, Garcia Rubio J, Cordero A, et al
    Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials.
    J Am Coll Cardiol. 2018;71:2710.
    PubMed     Text format    


    JAMA

  57. JONAS DE, Reddy S, Middleton JC, Barclay C, et al
    Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;319:2315-2328.
    PubMed     Text format     Abstract available

  58. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;319:2308-2314.
    PubMed     Text format     Abstract available

  59. JIN J
    Screening for Cardiovascular Disease Risk With ECG.
    JAMA. 2018;319:2346.
    PubMed     Text format    

  60. MCCARTHY CP, Vaduganathan M, Januzzi JL Jr
    Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment.
    JAMA. 2018 Jun 11. pii: 2684931. doi: 10.1001/jama.2018.7125.
    PubMed     Text format    


    N Engl J Med

  61. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
    PubMed     Text format    

  62. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
    PubMed     Text format     Abstract available


    Thromb Haemost

  63. COELHO-LIMA J, Mohammed A, Cormack S, Jones S, et al
    Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.
    Thromb Haemost. 2018 Jun 11. doi: 10.1055/s-0038-1660437.
    PubMed     Text format     Abstract available

  64. ZAKAI NA, Judd SE, Kissela B, Howard G, et al
    Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).
    Thromb Haemost. 2018 Jun 11. doi: 10.1055/s-0038-1655766.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: